← Leaderboards
Rangaraj Selvarangan
Children'S Mercy Hosp (Kansas City, Mo)
$12,239,109
Attributed
$21,211,286
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2011–25$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$21,211,286 · 3
By mechanism
U01$21,211,286 · 3
Top collaborators
- Christopher Harrison8 shared
- Jennifer E Schuster6 shared
Grant awards (25)
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$2,000,000
U01 · FY2025 · IP · contact PI
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$1,234,285
U01 · FY2024 · IP · contact PI
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$2,749,996
U01 · FY2023 · IP · contact PI
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$2,300,000
U01 · FY2023 · IP · contact PI
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$1,936,000
U01 · FY2022 · IP · contact PI
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$1,441,647
U01 · FY2021 · IP · contact PI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$1,505,484
U01 · FY2020 · IP · contact PI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$1,000,000
U01 · FY2019 · IP · contact PI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$1,226,942
U01 · FY2018 · IP · contact PI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$300,000
U01 · FY2018 · IP · contact PI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$250,000
U01 · FY2018 · IP · contact PI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$1,000,000
U01 · FY2017 · IP · contact PI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$785,715
U01 · FY2016 · IP · contact PI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$214,285
U01 · FY2016 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$499,998
U01 · FY2015 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$385,714
U01 · FY2015 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$214,285
U01 · FY2015 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$391,529
U01 · FY2014 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$191,291
U01 · FY2014 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$391,529
U01 · FY2013 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$158,471
U01 · FY2013 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$271,003
U01 · FY2012 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$255,867
U01 · FY2012 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$306,025
U01 · FY2011 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases-Patient Protection-ACA$201,220
U01 · FY2011 · IP · contact PI